Cirrhosis |
Cirrhosis (Primary Biliary); Cirrhosis of the Liver; Liver Cirrhosis |
Clinical Trial: Renal and Cardiovascular Effects of Terlipressin in Patients with Cirrhosis and Ascites
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function.
Hypothesis: Significant improvement of renal function reflected by: glomerular filtration rate (GFR), renal blood flow (RBF), excretion of salt and metabolites in the urine and related hormones and peptides in the blood. No effect on the systolic function of the heart.
| Condition | Intervention | Phase |
|---|---|---|
| Cirrhosis Ascites | Drug: Terlipressin | Phase II Phase III |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study
Eligibility
Inclusion Criteria:
- Cirrhosis and ascites
Location and Contact Information
Denmark, Hvidovre
Hvidovre Hospital, Copenhagen, Hvidovre, 2650, Denmark; Recruiting
Aleksander Krag Krag, MD, Principal Investigator
Aleksander Krag Krag, MD, Principal Investigator, Hvidovre Hospital
More Information
Record last reviewed: June 2005
Last Updated: June 30, 2005
Record first received: June 26, 2005
ClinicalTrials.gov Identifier: NCT00115947
Health Authority: Denmark: Danish Medicines Agency
ClinicalTrials.gov processed this record on 2005-07-05
Resources
- Alcohol Alert #42. Alcohol and the Liver (National Institute on Alcohol Abuse and Alcoholism)
- Alcoholic Hepatitis (Mayo Foundation for Medical Education and Research)

Not Signed In -

